Privia Health Group, Inc. (PRVA) stock
PRVANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3054% above fair value
$23.67−0.37 (-1.54%)
Close on Nov 12, 2026Market cap $3.02BP/E 91.0Yield –
Privia Health cash
Cash and short-term investments held at the end of each period.
Privia Health's cash was $446.28M at Sep 30, 2026. For fiscal 2025 it was $479.69M, down 2.3% from the year before. The highest annual figure on record is $491.15M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $479.69M | -2.3% |
| FY2024 | Dec 31, 2024 | $491.15M | +26.1% |
| FY2023 | Dec 31, 2023 | $389.51M | +11.9% |
| FY2022 | Dec 31, 2022 | $347.99M | +8.6% |
| FY2021 | Dec 31, 2021 | $320.58M | +278.8% |
| FY2020 | Dec 31, 2020 | $84.63M | +80.5% |
| FY2019 | Dec 31, 2019 | $46.89M | +19.9% |
| FY2018 | Dec 31, 2018 | $39.11M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $446.28M | +1.1% |
| Q2 FY2026 | Jun 30, 2026 | $412.20M | +5.7% |
| Q1 FY2026 | Mar 31, 2026 | $419.52M | -10.6% |
| Q4 FY2025 | Dec 31, 2025 | $479.69M | -2.3% |
| Q3 FY2025 | Sep 30, 2025 | $441.35M | +4.6% |
| Q2 FY2025 | Jun 30, 2025 | $390.13M | +0.7% |
| Q1 FY2025 | Mar 31, 2025 | $469.33M | +33.7% |
| Q4 FY2024 | Dec 31, 2024 | $491.15M | +26.1% |
| Q3 FY2024 | Sep 30, 2024 | $422.00M | +27.7% |
| Q2 FY2024 | Jun 30, 2024 | $387.35M | +21.8% |
| Q1 FY2024 | Mar 31, 2024 | $351.14M | +12.8% |
| Q4 FY2023 | Dec 31, 2023 | $389.51M | +11.9% |
| Q3 FY2023 | Sep 30, 2023 | $330.39M | +4.3% |
| Q2 FY2023 | Jun 30, 2023 | $317.95M | +8.8% |
| Q1 FY2023 | Mar 31, 2023 | $311.23M | -1.5% |
| Q4 FY2022 | Dec 31, 2022 | $347.99M | +8.6% |
| Q3 FY2022 | Sep 30, 2022 | $316.90M | -12.5% |
| Q2 FY2022 | Jun 30, 2022 | $292.19M | -2.5% |
| Q1 FY2022 | Mar 31, 2022 | $315.93M | +285.6% |
| Q4 FY2021 | Dec 31, 2021 | $320.58M | +278.8% |
| Q3 FY2021 | Sep 30, 2021 | $362.11M | +310.6% |
| Q2 FY2021 | Jun 30, 2021 | $299.75M | +377.6% |
| Q1 FY2021 | Mar 31, 2021 | $81.94M | +64.5% |
| Q4 FY2020 | Dec 31, 2020 | $84.63M | +80.5% |
| Q3 FY2020 | Sep 30, 2020 | $88.19M | +125.5% |
| Q2 FY2020 | Jun 30, 2020 | $62.76M | – |
| Q1 FY2020 | Mar 31, 2020 | $49.80M | – |
| Q4 FY2019 | Dec 31, 2019 | $46.89M | – |
| Q4 FY2018 | Dec 31, 2018 | $39.11M | – |
See a number that looks wrong?